Characterization of the Asian myopathy patients with VCP mutations

Z Shi1, Y K Hayashi, S Mitsuhashi

  • 1Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Kodaira, Tokyo, Japan.

Abstract

Insights

Valosin-containing protein (VCP) gene mutations are a significant cause of adult-onset myopathy in Asian populations. Genetic analysis is recommended for patients presenting with rimmed vacuoles and neurogenic changes.

Area of Science:

  • Genetics
  • Neurology
  • Pathology

Background:

  • Mutations in the valosin-containing protein (VCP) gene are associated with IBMPFD and familial ALS.
  • Previous reports on IBMPFD in Asian families are limited, with only one documented case.

Purpose of the Study:

  • To investigate the prevalence and characteristics of VCP mutations in Asian families with suspected rimmed vacuolar myopathy.
  • To identify novel VCP mutations and their associated clinical and pathological features.

Main Methods:

  • Screened 152 unrelated Asian families with suspected rimmed vacuolar myopathy for VCP mutations.
  • Characterized identified mutations and analyzed clinical, skeletal muscle, and pathological findings.

Main Results:

  • Identified VCP mutations in seven patients from six unrelated Asian families, including a novel p.Ala439Pro substitution.
  • Patients presented with adult-onset progressive muscle wasting, variable neurological involvement (cerebellar ataxia), and rare bone abnormalities.
  • Skeletal muscle biopsies showed rimmed vacuoles, cytoplasmic/nuclear inclusions (VCP, ubiquitin, TDP-43, HDAC6), and evidence of nuclear/mitochondrial damage.

Conclusions:

  • VCP mutations are not rare in Asian patients with adult-onset rimmed vacuolar myopathy.
  • Genetic analysis for VCP mutations should be considered in patients with adult-onset rimmed vacuolar myopathy and neurogenic changes.
  • Diverse neurological and rare skeletal manifestations can complicate the diagnosis of VCP-related disorders.

Related Concept Videos

Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...